AVLN

Conviction 12HealthcareScan · Thu, Sep 24, 2026

Hammer

Avalyn Pharma Inc. (AVLN) closed at $28.57 (-3.71%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day. RSI(14) 32, -27.2% from its 52-week high, -3.1% year to date. Sector: Healthcare · Biotechnology.

AVLN$28.57-3.71%

ResistanceSupportVol 14Insider buy

Vol MA14 282.52K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Avalyn Pharma Inc.Biotechnologywww.avalynpharma.com ↗

Price28.57

Change-3.71%

Gap-1.82%

Rel volume—

Avg volume256.83K

Avg $ vol8.67M

SMA 2034.13

SMA 5033.36

SMA 200—

Price vs 50-14.35%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 35.57

RSI (14)32

MACD hist-0.81

MACD cross—

Stoch %K / %D10 / 12

ADX (14)23

+DI / −DI10 / 29

RSI divergence—

MACD divergence—

ATR %8.26%

ADR %6.55%

52w high39.25

52w low25.68

From 52w high-27.21%

Above 52w low+11.25%

New 52w highNo

SqueezeOff

Bollinger width27.02%

%B-0.10

Donchian pos10.28%

Donchian high38.70

Donchian low27.41

AVWAP (52w high)34.65

vs AVWAP high-17.55%

AVWAP (52w low)31.24

vs AVWAP low-8.55%

OBV trendFlat

Chaikin MF (20)-0.19

Today vs 20d—

Avg vol (14d)282.52K

Avg vol (20d)256.83K

Avg $ vol (20d)8.67M

Market cap1.27B

RS Rating—

RS 3m (vs SPY)-5.91%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank9.9

1 week-14.54%

1 month-25.21%

3 months-1.41%

6 months—

1 year—

YTD-3.12%

P/E—

P/B3.18

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.04

Current33.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target54.50

Target upside90.76%

Analyst ratingBuy

Institutional99.96%

Ent. value1.02B

Revenue—

Net income-28.93M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out44.33M

Employees—

ListedThu, Apr 30, 2026

Free float30.62M

Float %73.2%

Short interest1.93M

Days to cover11.3d

Short volume79.0%

Squeeze score58 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.98 vs −$1.03

Last surprise+4.8% beat

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank9.9 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVLN

All disclosures →

No recent disclosed trades by Congress in AVLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVLN · open-market 1 buy

Insider	Side	Shares	Value	Traded	Filed
Meyer Robert J. Director · Stock Option (Right to Buy) · 2026-09-15	Grant	31.18K	—	2026-09-15	2026-09-17
Novo Holdings A/S 10% owner · Series D Preferred Stock · 2026-05-01	Convert	12.56M	$0	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
Novo Holdings A/S 10% owner · Voting Common Stock · 2026-05-01	Buy	555.55K	$10.0M	2026-05-01	2026-05-05
FMR LLC 10% owner · Series A Preferred Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series D Preferred Stock · 2026-05-01	Convert	377.95K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series B Preferred Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series C-2 Preferred Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05

SEC filings

EDGAR filings in AVLN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

AVLN

Recent news

Get daily signals & real-time alerts.